Biểu đồ giá cổ phiếu NRXP
NRXP Cổ tức
NRX Pharmaceuticals Inc
$2.95
2.78%
$0.08
Khi đóng cửa: May 13, 16:00:00 GMT-4
$2.97
0.67%
$0.02
Phiên sau giờ: May 13, 18:31:56 GMT-4
Quay lại
NRX Pharmaceuticals Inc (NRXP) Cổ tức
Thống kê chính
Giá đóng cửa trước
$2.87
Giá mở cửa
$2.93
Phạm vi ngày
$2.9 - $3.02
Phạm vi 52 tuần
$1.62 - $3.84
Khối lượng
750.6K
Khối lượng trung bình
927.3K
Tỷ suất cổ tức
--
EPS (TTM)
-1.57
Vốn hóa thị trường
$98.2M
NRXP là gì?
NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is headquartered in Wilmington, Delaware. The company went IPO on 2017-11-20. The company is developing NRX-100 (preservative-free intravenous ketamine) and NRX-101, (oral D-cycloserine/lurasidone). NRX-100 has been awarded Fast Track Designation for the treatment of Suicidal Ideation in Depression, including Bipolar Depression. NRX-101 has been awarded Breakthrough Therapy Designation for the treatment of suicidal bipolar depression. NRx has filed an Abbreviated New Drug Application (ANDA) and initiated a New Drug Application filing for NRX-100 (IV ketamine) with an application for the Commissioner’s National Priority Voucher Program for the treatment of suicidal depression. Its subsidiary, HOPE Therapeutics, Inc., is a healthcare delivery company that is building a network of interventional psychiatry clinics.
